← FDA DRUG APPROVALS

FDA ANDA · ANDA062036

AEROSPORIN

Sponsor: GLAXOSMITHKLINE

APPLICATION
ANDA062036
TYPE
ANDA
ORIGINAL APPROVAL
1980-11-13
LATEST ACTION
1998-02-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AEROSPORINDiscontinued
POLYMYXIN B SULFATE EQ 500,000 UNITS BASE/VIAL · INJECTABLE · INJECTION

Approval history

1998-02-23Labeling · Supplement 1AP
1980-11-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →